CRANFORD, N.J., March 10, 2026 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), an oncology?focused biopharmaceutical company and majority ...

Merck (NYSE:MRK) reported a series of positive late stage clinical trial results for oncology and HIV therapies, including new Phase 3 data for KEYTRUDA and WELIREG regimens in kidney, ovarian, and ...

Clinicians must consider patient comorbidities and therapy safety when selecting immunotherapy for cSCC, says Todd ...

Indian national Sanjay Kumar has been sentenced to nearly four years in prison for carrying out a conspiracy to sell fake ...

A 45-year-old Indian national has been sentenced to 43 months in prison for conspiring to sell tens of thousands of dollars’ worth of counterfeit cancer medication that he privately compared to “just ...

A 45-year-old Indian national, Sanjay Kumar, was sentenced Thursday to 43 months in federal prison for his role in a ...

A Massachusetts federal court has sentenced an Indian national to more than three years in prison after he admitted to ...

A 45-year-old foreign national has been sentenced to federal prison for selling counterfeit oncology pharmaceuticals in the United States, according to U.S. Attorney Nicholas J. Ganjei.

A 45-year-old man has been sentenced to prison for his role in selling tens of thousands of dollars' worth of counterfeit ...

A man who shipped counterfeit cancer drugs to Houston was sentenced to 43 months in federal prison after pleading guilty to ...

The study explores the neoadjuvant approach: administering the immunotherapy drug Keytruda (pembrolizumab) before a surgeon ever picks up a scalpel. Researchers observed dramatic tumor shrinkage and, ...

Oncology projects currently take up about 40% of Pfizer’s overall R&D budget. | After steering positive key pivotal readouts for a trio of Novartis’ blockbusters, Jeff Legos is now tasked with ...